procainamide has been researched along with Diabetic Glomerulosclerosis in 1 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Low, CL | 1 |
| Phelps, KR | 1 |
| Bailie, GR | 1 |
1 other study available for procainamide and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Relative efficacy of haemoperfusion, haemodialysis and CAPD in the removal of procainamide and NAPA in a patient with severe procainamide toxicity.
Topics: Acecainide; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Diabetic Nephropathies; Hemoperfusion | 1996 |